​

Funding Round

Series C - Genetesis

Series C - Genetesis

Investment Firm

Overview

Genetesis is a rapidly growing medical imaging company leveraging data science and biomagnetism in the fight against cardiovascular disease

Announced Date

Oct 06, 2022

Funding Type

Series C

Highlights

Location

United States, North America

Social

Investor Lead

Mithril Capital Management

Mithril Capital Management

Mithril Capital Management is a early_stage_venture and late_stage_venture and seed and venture firm.

Participant Investors

6

Investor Name
Participant InvestorJobsOhio
Participant InvestorMithril Capital Management
Participant InvestorOhio Innovation Fund
Participant InvestorCercano Management
Participant InvestorCincyTech

Round Details and Background

Genetesis raised $17500000 on 2022-10-06 in Series C

Genetesis is a rapidly growing medical imaging company leveraging data science and biomagnetism in the fight against cardiovascular disease

Company Funding History

8

Announcment DateTransaction NameNumber Of InvestorsLead InvestorMoney Raised
Oct 18, 2021
Venture Round - Genetesis
1-150.0K
May 01, 2017
Grant - Genetesis
1-undefined
Oct 30, 2014
Pre Seed Round - Genetesis
1-260.0K
Nov 14, 2016
Seed Round - Genetesis
4-1.2M

Recent Activity

There is no recent news or activity for this profile.